Abstract
Sirtuins (Sirts) regulate several cellular mechanisms through deacetylation of several transcription factors and enzymes. Recently, Sirt2 was shown to prevent the development of inflammatory processes and its expression favors acute Listeria monocytogenes infection. The impact of this molecule in the context of chronic infections remains unknown. We found that specific Sirt2 deletion in the myeloid lineage transiently increased Mycobacterium tuberculosis load in the lungs and liver of conditional mice. Sirt2 did not affect long-term infection since no significant differences were observed in the bacterial burden at days 60 and 120 post-infection. The initial increase in M. tuberculosis growth was not due to differences in inflammatory cell infiltrates in the lung, myeloid or CD4+ T cells. The transcription levels of IFN-γ, IL-17, TNF, IL-6 and NOS2 were also not affected in the lungs by Sirt2-myeloid specific deletion. Overall, our results demonstrate that Sirt2 expression has a transitory effect in M. tuberculosis infection. Thus, modulation of Sirt2 activity in vivo is not expected to affect chronic infection with M. tuberculosis.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
CD4-Positive T-Lymphocytes / microbiology
-
Disease Models, Animal
-
Female
-
Flow Cytometry
-
Gene Deletion
-
Gene Expression Regulation*
-
Inflammation
-
Interferon-gamma / metabolism
-
Interleukin-17 / metabolism
-
Interleukin-6 / metabolism
-
Liver / microbiology
-
Lung / microbiology
-
Macrophages / metabolism
-
Macrophages / microbiology
-
Male
-
Mice
-
Mycobacterium tuberculosis / metabolism*
-
Myeloid Cells / metabolism*
-
Nitric Oxide Synthase Type II / metabolism
-
Real-Time Polymerase Chain Reaction
-
Sirtuin 2 / metabolism*
-
Tuberculosis, Pulmonary / metabolism*
-
Tuberculosis, Pulmonary / microbiology
-
Tumor Necrosis Factor-alpha / metabolism
Substances
-
Il17a protein, mouse
-
Interleukin-17
-
Interleukin-6
-
Tumor Necrosis Factor-alpha
-
interleukin-6, mouse
-
Interferon-gamma
-
Nitric Oxide Synthase Type II
-
Nos2 protein, mouse
-
Sirt2 protein, mouse
-
Sirtuin 2
Grants and funding
This work was funded by Fundação para a Ciência e Tecnologia, Portugal and cofunded by Programa Operacional Regional do Norte (ON.2–O Novo Norte), Quadro de Referência Estratégico Nacional (QREN), through the Fundo Europeu de Desenvolvimento Regional (FEDER). Project grants: PTDC/SAU-MII/101977/2008 (to AGC) and PTDC/BIA-BCM/102776/2008 (to MS). LMT was supported by FCT Grant SFRH/BPD/77399/201. MS is an Associate-FCT Investigator fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.